Detalhe da pesquisa
1.
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Pediatr Hematol Oncol
; 40(2): 147-158, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35838057
2.
Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors.
Org Biomol Chem
; 18(17): 3288-3296, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32286579
3.
Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
Pediatr Hematol Oncol
; 37(1): 76-89, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682773
4.
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group.
Pediatr Blood Cancer
; 66(9): e27827, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330093
5.
A STAT3 decoy lures AML out of hiding.
Blood
; 127(13): 1628-9, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27034418
6.
Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.
Br J Haematol
; 170(5): 704-18, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25974135
7.
FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
Blood
; 121(7): 1083-93, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23243289
8.
Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity.
Angew Chem Int Ed Engl
; 54(44): 13085-9, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26480340
9.
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.
Biomedicines
; 12(2)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397996
10.
Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.
Blood
; 117(21): 5701-9, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21447830
11.
ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Biomedicines
; 11(7)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509482
12.
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.
Cancers (Basel)
; 15(4)2023 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831684
13.
Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions.
Children (Basel)
; 8(8)2021 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34438589
14.
Comparison of the Transcriptomic Signatures in Pediatric and Adult CML.
Cancers (Basel)
; 13(24)2021 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34944883
15.
Ligand-induced STAT3 signaling increases at relapse and is associated with outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Haematologica
; 100(12): e496-500, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294728
16.
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia.
J Immunother Cancer
; 8(2)2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938629
17.
Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.
Leukemia
; 33(1): 52-63, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884904
18.
Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
Blood Adv
; 3(24): 4215-4227, 2019 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31856268
19.
Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern.
J Leukoc Biol
; 82(4): 975-85, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17634277
20.
Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report.
Oncotarget
; 8(52): 90037-90049, 2017 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29163809